Loading data for RBGLY — first visit, this takes a few seconds.
Reckitt Benckiser Group (RBGLY)
OTC Markets OTCQX: RBGLY
· Real-Time Price · USD
13.69
-0.27 (-1.93%)
At close: Aug 17, 2026, 8:00 PM
Reckitt Benckiser Group (RBGLY) Stock Price, Analysis & Data
-1.93% (1D)
No data available
| Bid | n/a |
| Market Cap | 43.46B |
| Revenue (ttm) | 13.64B |
| Net Income (ttm) | 2.89B |
| Beta | 0.26 |
| EPS (ttm) | 1.17 |
| PE Ratio (ttm) | 11.7 |
| Forward PE | 14.15 |
| P/B (ttm) | 5.68 |
| P/S (ttm) | 3.19 |
| Earnings Date | Mar 4, 2027 |
| Ask | n/a |
| Volume | 72,457 |
| Avg. Volume (20D) | 762,778 |
| Open | 13.70 |
| Previous Close | 13.96 |
| Day's Range | 13.66 - 13.74 |
| 52-Week Range | 12.02 - 17.80 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.58 (4.14%) |
| Ex-Dividend Date | Aug 10, 2026 |
About RBGLY
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, Delsym, Cepacol, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supple...
Industry Household & Personal Products
Sector Consumer Defensive
IPO Date Oct 15, 2008
Employees 36,200
Stock Exchange OTC Markets OTCQX
Ticker Symbol RBGLY
Website https://www.reckitt.com
Financial Performance
In 2025, Reckitt Benckiser's revenue was 14.21B, an increase of 0.25% compared to the previous year's 14.17B. Earnings were 3.18B, an increase of 123.14%.
Financial StatementsReckitt Benckiser Group is scheduled to release its earnings on Mar 4, 2027, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2